FMP
Profound Medical Corp.
PRN.TO
TSX
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
10.04 CAD
-0.02 (-0.199%)
About
ceo
Dr. Arun Swarup Menawat MBA, Ph.D.
sector
Healthcare
industry
Medical - Devices
website
https://www.profoundmedical.com
exchange
TSX
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
CIK
N/A
ISIN
CA74319B5027
CUSIP
N/A
Address
2400 Skymark Avenue
Phone
647 476 1350
Country
CA
Employee
131
IPO Date
Jul 10, 2018
Key Executives
